EMPDHIGH SIGNALFINANCIAL10-K

EMPD experienced a dramatic revenue decline while substantially improving gross profit margins, suggesting significant operational restructuring or business model changes.

The company's revenue dropped by three-quarters while gross losses were meaningfully reduced, indicating either a major strategic pivot toward higher-margin business or severe operational contraction. The simultaneous reduction in inventory levels and capital expenditures suggests active downsizing, though operating cash flow deterioration persists, raising questions about the sustainability of current operations.

Comparing 2026-03-27 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

EMPD's financial profile shifted dramatically with revenue declining by three-quarters to under $1 million while gross profit margins improved substantially, moving from significant losses to near break-even. The company reduced inventory by over three-quarters and cut capital expenditures by one-third, indicating aggressive cost management and operational downsizing. However, operating cash flow remained deeply negative and worsened slightly, suggesting the business continues to consume cash despite the dramatic restructuring efforts.

FINANCIAL STATEMENT CHANGES
Gross Profit
P&L
+97.4%
-$14.1M-$363K

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Inventory
Balance Sheet
-77.3%
$1.5M$331K

Inventory drawn down 77.3% — strong sell-through or deliberate destocking; watch for supply constraints.

Revenue
P&L
-75.9%
$4.0M$975K

Revenue declined 75.9% — significant demand weakness or market share loss warrants investigation.

Capital Expenditure
Cash Flow
-34.3%
$312K$205K

Capex reduced 34.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Total Debt
Balance Sheet
-24%
$45K$35K

Debt reduced 24% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Cash Flow
Cash Flow
-11.3%
-$16.0M-$17.8M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-03-27
PRIOR — 2025-03-31
ADDED
These forward-looking statements generally can be identified by the use of words such as anticipate, expect, plan, could, may, believe, estimate, forecast, goal, potentially, project, and other words of similar meaning.
Risk Factors contained in this Annual Report on Form 10-K and in any subsequent filings with the SEC.
As a result of these and other factors, we may not achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements.
We do not assume and specifically disclaim any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Our business is subject to substantial risks and uncertainties, including those referenced above.
Investors, potential investors, and others should give careful consideration to these risks and uncertainties.
iii Summary of Risk Factors Below is a summary of the principal factors that make an investment in our common stock speculative or risky.
Additional discussion of the risks summarized in this risk factor summary and other risks that we face can be found below under the heading Part I, Item 1A.
Risk Factors and should be carefully considered, together with other information in this Annual Report on Form 10-K and our other filings with the SEC, before making an investment decision regarding our common stock.
Our losses from operations could raise substantial doubt regarding our ability to continue as a going concern.
REMOVED
We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with these safe harbor provisions.
In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing.
We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us.
Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; our product development and production releases; and our business prospects and opportunities.
You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as may, should, expects, anticipates, contemplates, estimates, believes, plans, projected, predicts, potential, or hopes or the negative of these or similar terms.
In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business.
The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us.
We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.
While we believe we have identified material risks, these risks and uncertainties are not exhaustive.
Other sections of this Form 10-K describe additional factors that could adversely impact our business and financial performance.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →